Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Change in Receivables (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Change in Receivables for 3 consecutive years, with $294739.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables fell 66.18% year-over-year to $294739.0, compared with a TTM value of $4.7 million through Sep 2025, down 71.49%, and an annual FY2024 reading of -$1.4 million, down 106.03% over the prior year.
  • Change in Receivables was $294739.0 for Q3 2025 at SBC Medical Group Holdings, down from $494072.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $21.5 million in Q4 2023 and bottomed at -$4.8 million in Q1 2024.
  • Average Change in Receivables over 3 years is $2.7 million, with a median of $394788.5 recorded in 2025.
  • The sharpest move saw Change in Receivables plummeted 83.14% in 2024, then soared 146.28% in 2025.
  • Year by year, Change in Receivables stood at $21.5 million in 2023, then tumbled by 83.14% to $3.6 million in 2024, then crashed by 91.86% to $294739.0 in 2025.
  • Business Quant data shows Change in Receivables for SBC at $294739.0 in Q3 2025, $494072.0 in Q2 2025, and $295505.0 in Q1 2025.